tiprankstipranks
Trending News
More News >
Todos Medical Ltd. (TOMDF)
OTHER OTC:TOMDF
US Market

Todos Medical (TOMDF) Ratios

Compare
68 Followers

Todos Medical Ratios

TOMDF's free cash flow for Q4 2022 was $1.00. For the 2022 fiscal year, TOMDF's free cash flow was decreased by $ and operating cash flow was $-1.46. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.20 0.53 0.30 0.02-
Quick Ratio
0.14 0.35 0.24 0.02-
Cash Ratio
<0.01 0.02 0.12 <0.01-
Solvency Ratio
-0.48 -1.89 -1.90 -1.54-
Operating Cash Flow Ratio
-0.16 -1.25 -0.32 -0.82-
Short-Term Operating Cash Flow Coverage
-0.51 -5.55 -0.86 -11.33-
Net Current Asset Value
$ -46.78M$ -34.61M$ -14.57M$ -6.31M-
Leverage Ratios
Debt-to-Assets Ratio
2.51 2.10 1.90 42.36-
Debt-to-Equity Ratio
-1.08 -1.31 -1.04 -0.62-
Debt-to-Capital Ratio
13.52 4.21 26.49 -1.61-
Long-Term Debt-to-Capital Ratio
-13.14 5.50 -3.32 -1.49-
Financial Leverage Ratio
-0.43 -0.62 -0.55 -0.01-
Debt Service Coverage Ratio
-0.47 -1.35 -2.47 -5.39-
Interest Coverage Ratio
-0.66 -0.32 -3.72 -3.67-
Debt to Market Cap
2.72K 0.80 0.59 1.05-
Interest Debt Per Share
0.04 0.09 0.06 0.05-
Net Debt to EBITDA
-4.08 -3.25 -0.74 -0.49-
Profitability Margins
Gross Profit Margin
56.01%35.84%26.68%0.00%-
EBIT Margin
-131.83%-85.67%-314.98%0.00%-
EBITDA Margin
-122.08%-79.44%-272.04%0.00%-
Operating Profit Margin
-126.68%-75.93%-273.88%0.00%-
Pretax Profit Margin
-324.64%-354.16%-571.79%0.00%-
Net Profit Margin
-324.81%-612.60%-622.32%0.00%-
Continuous Operations Profit Margin
-324.64%-354.16%-571.79%0.00%-
Net Income Per EBT
100.05%172.97%108.84%83.01%-
EBT Per EBIT
256.27%466.44%208.77%336.10%-
Return on Assets (ROA)
-163.71%-495.67%-539.26%-10789.16%-
Return on Equity (ROE)
83.70%309.44%294.29%156.95%-
Return on Capital Employed (ROCE)
748.69%-150.87%692.28%239.00%-
Return on Invested Capital (ROIC)
-243.89%-196.41%-1690.77%214.85%-
Return on Tangible Assets
-1872.21%-1012.58%-539.26%-10789.16%-
Earnings Yield
-175317.38%-190.08%-166.70%-266.44%-
Efficiency Ratios
Receivables Turnover
7.34 4.85 13.78 0.00-
Payables Turnover
0.51 3.45 2.33 0.07-
Inventory Turnover
3.32 4.90 7.12 0.00-
Fixed Asset Turnover
5.35 5.59 2.60 0.00-
Asset Turnover
0.50 0.81 0.87 0.00-
Working Capital Turnover Ratio
-0.88 -2.48 -1.46 0.00-
Cash Conversion Cycle
-552.19 43.90 -79.05 -5.10K-
Days of Sales Outstanding
49.71 75.21 26.50 0.00-
Days of Inventory Outstanding
110.09 74.56 51.24 0.00-
Days of Payables Outstanding
711.99 105.87 156.78 5.10K-
Operating Cycle
159.80 149.77 77.74 0.00-
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.02 >-0.01 -0.01-
Free Cash Flow Per Share
>-0.01 -0.02 -0.02 -0.01-
CapEx Per Share
<0.01 <0.01 <0.01 <0.01-
Free Cash Flow to Operating Cash Flow
1.03 1.10 1.97 1.00-
Dividend Paid and CapEx Coverage Ratio
-36.66 -10.23 -1.03 -1.19K-
Capital Expenditure Coverage Ratio
-36.66 -10.23 -1.03 -1.19K-
Operating Cash Flow Coverage Ratio
-0.07 -0.35 -0.22 -0.33-
Operating Cash Flow to Sales Ratio
-0.35 -0.92 -0.49 0.00-
Free Cash Flow Yield
-19792.63%-31.26%-25.92%-34.70%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.53 -0.60 -0.38-
Price-to-Sales (P/S) Ratio
<0.01 3.22 3.73 0.00-
Price-to-Book (P/B) Ratio
>-0.01 -1.63 -1.77 -0.59-
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -3.20 -3.86 -2.88-
Price-to-Operating Cash Flow Ratio
>-0.01 -3.51 -7.60 -2.88-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.03 -0.03 >-0.01-
Price-to-Fair Value
>-0.01 -1.63 -1.77 -0.59-
Enterprise Value Multiple
-4.08 -7.31 -2.11 -0.97-
Enterprise Value
38.33M 70.98M 29.95M 7.52M-
EV to EBITDA
-4.08 -7.31 -2.11 -0.97-
EV to Sales
4.98 5.80 5.75 0.00-
EV to Free Cash Flow
-13.75 -5.76 -5.94 -5.89-
EV to Operating Cash Flow
-14.13 -6.32 -11.71 -5.89-
Tangible Book Value Per Share
-0.03 -0.05 -0.04 -0.07-
Shareholders’ Equity Per Share
-0.02 -0.04 -0.04 -0.07-
Tax and Other Ratios
Effective Tax Rate
>-0.01 -0.73 -0.09 0.17-
Revenue Per Share
<0.01 0.02 0.02 0.00-
Net Income Per Share
-0.02 -0.11 -0.13 -0.11-
Tax Burden
1.00 1.73 1.09 0.83-
Interest Burden
2.46 4.13 1.82 1.51-
Research & Development to Revenue
0.08 0.07 1.89 0.00-
SG&A to Revenue
0.00 0.77 1.11 0.00-
Stock-Based Compensation to Revenue
0.00 0.10 0.50 0.00-
Income Quality
0.11 0.26 0.09 0.11-
Currency in USD